Curaleaf plans bid for Aurora Cannabis at implied US$4 a share
Curaleaf outlines cash-and-stock bid for Aurora
Curaleaf outlined plans to buy Aurora Cannabis in a cash-and-stock deal valued at US$4 per Aurora share.
- Consideration set at 0.35 Curaleaf subordinate voting shares, cash of US$0.75 for each Aurora share.
- Terms imply a 45% premium to Aurora’s 30-day VWAP of US$2.75.
- Value capped at US$5 per share if Curaleaf’s 20-day VWAP rises sharply, with the share ratio adjusted.
- Curaleaf targets at least US$40 million in annual cost synergies, citing complementary EU-GMP capacity and international distribution.
